FdaApplication
ANDA 218031
Identifiers
- fda_app_no: ANDA218031
Properties
| Property | Value |
|---|---|
| applicant_name | NOVAST LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-10-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROSPIRENONE AND ESTRADIOL | DROSPIRENONE; ESTRADIOL | 0.5MG;1MG | TABLET;ORAL |
1 product